Related content

PTK787/ZK222584 Combined with Interferon Alpha and 5-Fluorouracil Synergistically Inhibits VEGF Signaling Pathway in Hepatocellular Carcinoma

By Katsura Yoshiteru   Wada Hiroshi   Murakami Masahiro   Akita Hirofumi   Hama Naoki   Kawamoto Koichi   Kobayashi Shogo   Marubashi Shigeru   Eguchi Hidetoshi   Tanemura Masahiro   Umeshita Koji   Doki Yuichiro   Mori Masaki   Nagano Hiroaki  

Annals of Surgical Oncology, Vol. 20, Iss. 3, 2013-12 ,pp. : 517-526

Springer Publishing Company

Access to resources Recommend Favorite

Biomarkers for assessment of pharmacologic activity for a vascular endothelial growth factor (VEGF) receptor inhibitor, PTK787/ZK 222584 (PTK/ZK): translation of biological activity in a mouse melanoma metastasis model to phase I studies in patients with advanced colorectal cancer with liver metastases

By Lee Lucy   Sharma Sunil   Morgan Bruno   Allegrini Peter   Schnell Christian   Brueggen Josef   Cozens Robert   Horsfield Mark   Guenther Clemens   Steward Will   Drevs Joachim   Lebwohl David   Wood Jeanette   McSheehy Paul  

Cancer Chemotherapy and Pharmacology, Vol. 57, Iss. 6, 2006-06 ,pp. : 761-771

Springer Publishing Company

Access to resources Recommend Favorite

The inhibition of tyrosine kinase receptor signalling in leiomyosarcoma cells using the small molecule kinase inhibitor PTK787/ZK222584 (Vatalanib®)

By  

International Journal of Oncology, Vol. 45, Iss. 6, 2014-01 ,pp. : 2267-2277

Spandidos Publications

Access to resources Recommend Favorite

Phase I trial with biomarker studies of vatalanib (PTK787) in patients with newly diagnosed glioblastoma treated with enzyme inducing anti-epileptic drugs and standard radiation and temozolomide

By Gerstner Elizabeth   Eichler April   Plotkin Scott   Drappatz Jan   Doyle Colin   Xu Lei   Duda Dan   Wen Patrick   Jain Rakesh   Batchelor Tracy  

Journal of Neuro-Oncology, Vol. 103, Iss. 2, 2011-06 ,pp. : 325-332

Springer Publishing Company

Access to resources Recommend Favorite

Phase II Trial of Vinorelbine in Recurrent and Progressive Epithelial Ovarian Cancer

By Burger R.A.   DiSaia P.J.   Roberts J.A.   O'Rourke M.   Gershenson D.M.   Homesley H.D.   Lichtman S.M.   Barnes W.   Moore D.H.   Monk B.J.  

Gynecologic Oncology, Vol. 72, Iss. 2, 1999-02 ,pp. : 148-153

Elsevier

Access to resources Recommend Favorite